Delivery Order SPE2DB22D3501-SPE2DB26FTH92
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nateglinide 60 mg tablets (100-count units) with a ceiling value of $1,554.62. This firm fixed-price delivery order, which has a completion date of September 10, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,518.65 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) on October 21, 2025, with an ultimate completion date of October 22, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,079.18 to supply Nateglinide 120 mg tablets (100-count units) under a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside award was competitively procured and represents a child contract action originating from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,694.90 to AmerisourceBergen Drug Corp for 100 tablets of Nateglinide 60 mg, an oral antidiabetic medication. This competitive, non-set-aside delivery order, effective through September 18, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location under firm fixed price terms. The award represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,181.48 firm-fixed-price delivery order is for the supply of 4,568,061,670 units of the prescription medication Nateglinide 120 mg tablets. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,435 to Amerisourcebergen Drug Corporation to supply 120 mg tablets of nateglinide in unit doses of 30 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 8-11, 2023. This delivery order was issued against an existing DLA contract vehicle to support the agency's medical supply needs, but no additional...
- This federal contract award is for the delivery of 4,557,701,857 units of Nateglinide 120 mg tablets, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The firm-fixed-price delivery order, valued at $1,881.64, has a completion date of July 5, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,082.79, is for the delivery of Nateglinide 120 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...